A, K., S, R., L, W., A, G., V, K., Å, E., . . . C, G. (2024). Successful transport across continents of GMP-manufactured and cryopreserved culture-expanded human fetal liver-derived mesenchymal stem cells for use in a clinical trial. Regenerative therapy, 26, 324. https://doi.org/10.1016/j.reth.2024.06.012
Chicago Style (17th ed.) CitationA, Kumar, Ramesh S, Walther-Jallow L, Goos A, Kumar V, Ekblad Å, Madhuri V, and Götherström C. "Successful Transport Across Continents of GMP-manufactured and Cryopreserved Culture-expanded Human Fetal Liver-derived Mesenchymal Stem Cells for Use in a Clinical Trial." Regenerative Therapy 26 (2024): 324. https://doi.org/10.1016/j.reth.2024.06.012.
MLA (9th ed.) CitationA, Kumar, et al. "Successful Transport Across Continents of GMP-manufactured and Cryopreserved Culture-expanded Human Fetal Liver-derived Mesenchymal Stem Cells for Use in a Clinical Trial." Regenerative Therapy, vol. 26, 2024, p. 324, https://doi.org/10.1016/j.reth.2024.06.012.